Table 4.
Author | Method | Sample Size | Regions of Interest | Principal Findings |
---|---|---|---|---|
Tiihonen et al., 1997 | [123I] ß-CIT SPECT after SSRI | 11 GSAD; 11 HC | Striatum/White matter | Decreased DAT binding in GSAD, t=5.41, p<.001 |
Schneier et al., 2000 | [123I]IBZM SPECT | 10 GSAD; 10 HC | Striatum/Occipital Cortex | Decreased D2 receptor binding in GSAD, t=2.6, p=0.02 |
van der Wee et al., 2008 | [123I] ß-CIT SPECT after SSRI; MRI | 12 Medicationnaive GSAD; 12 HC | Striatum/Cerebellum | Increased DAT binding in GSAD, p=0.011 |
Schneier et al., 2008 | [123I]IBZM SPECT | 7 GSAD with OCD; 7 HC | Striatum/Occipital Cortex | Decreased D2 receptor binding in GSAD with OCD, Z=2.24, p=0.025 |
Farde et al., 1997 | [11C]raclopride PET, Scatchard procedure | 24 HC | Putamen | D2 receptor density correlated with detachment, r=-0.68, P<0.001 |
Breier et al., 1998 | [11C]raclopride PET | 18 HC | Striatum/Cerebellum | D2 receptor binding correlated with detachment, r=-0.49, p=0.04 |
Laakso et al., 2000 | [18F]CFT PET | 18 HC | Putamen, Caudate/Cerebellum | DAT binding in putamen, but not caudate, correlated with detachment, r=-0.45, p<0.04 |
GSAD=generalized social anxiety disorder subjects; HC=healthy control subjects; OCD = obsessive-compulsive disorder; DAT = dopamine tranporter